|
3-(tert-butoxycarbonylamino)-1-hydroxy-cyclobutanecarboxylic acid
|
H626740-5g
|
≥97% |
1067239-17-1 |
5g
|
¥ 22440.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(tert-butoxycarbonylamino)-1-hydroxy-cyclobutanecarboxylic acid
|
H626740-500mg
|
≥97% |
1067239-17-1 |
500mg
|
¥ 2994.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(tert-butoxycarbonylamino)-1-hydroxy-cyclobutanecarboxylic acid
|
H626740-250mg
|
≥97% |
1067239-17-1 |
250mg
|
¥ 1793.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(tert-butoxycarbonylamino)-1-hydroxy-cyclobutanecarboxylic acid
|
H626740-1g
|
≥97% |
1067239-17-1 |
1g
|
¥ 4488.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(tert-butoxycarbonylamino)-1-hydroxy-cyclobutanecarboxylic acid
|
H626740-100mg
|
≥97% |
1067239-17-1 |
100mg
|
¥ 1120.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5H,6H,7H-cyclopenta[b]pyridin-5-ol
|
H626731-5g
|
≥97% |
1065609-70-2 |
5g
|
¥ 7732.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5H,6H,7H-cyclopenta[b]pyridin-5-ol
|
H626731-500mg
|
≥97% |
1065609-70-2 |
500mg
|
¥ 856.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5H,6H,7H-cyclopenta[b]pyridin-5-ol
|
H626731-250mg
|
≥97% |
1065609-70-2 |
250mg
|
¥ 446.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5H,6H,7H-cyclopenta[b]pyridin-5-ol
|
H626731-1g
|
≥97% |
1065609-70-2 |
1g
|
¥ 1627.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(trifluoromethoxy)-1H-indazole
|
H626680-5g
|
≥97% |
105391-76-2 |
5g
|
¥ 4811.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(trifluoromethoxy)-1H-indazole
|
H626680-1g
|
≥97% |
105391-76-2 |
1g
|
¥ 1153.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(trifluoromethoxy)-1H-indazole
|
H626680-10g
|
≥97% |
105391-76-2 |
10g
|
¥ 9622.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-(trifluoromethoxy)-1H-indazole
|
H626679-5g
|
≥97% |
105391-43-3 |
5g
|
¥ 3769.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-(trifluoromethoxy)-1H-indazole
|
H626679-1g
|
≥97% |
105391-43-3 |
1g
|
¥ 988.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-(trifluoromethoxy)-1H-indazole
|
H626679-10g
|
≥97% |
105391-43-3 |
10g
|
¥ 7162.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S,4S,6R)-3-hexyl-4-hydroxy-6-undecyl-tetrahydropyran-2-one
|
H626661-5g
|
≥97% |
104801-96-9 |
5g
|
¥ 3008.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S,4S,6R)-3-hexyl-4-hydroxy-6-undecyl-tetrahydropyran-2-one
|
H626661-500mg
|
≥97% |
104801-96-9 |
500mg
|
¥ 453.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S,4S,6R)-3-hexyl-4-hydroxy-6-undecyl-tetrahydropyran-2-one
|
H626661-250mg
|
≥97% |
104801-96-9 |
250mg
|
¥ 339.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S,4S,6R)-3-hexyl-4-hydroxy-6-undecyl-tetrahydropyran-2-one
|
H626661-1g
|
≥97% |
104801-96-9 |
1g
|
¥ 604.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S,4S,6R)-3-hexyl-4-hydroxy-6-undecyl-tetrahydropyran-2-one
|
H626661-100mg
|
≥97% |
104801-96-9 |
100mg
|
¥ 253.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-硼酸频哪醇酯基-1-(三氟甲基)-1H-吡唑
|
H626659-250mg
|
≥97% |
1046831-98-4 |
250mg
|
¥ 264.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-硼酸频哪醇酯基-1-(三氟甲基)-1H-吡唑
|
H626659-1g
|
≥97% |
1046831-98-4 |
1g
|
¥ 880.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide
|
H626640-500mg
|
≥97% |
1038915-75-1 |
500mg
|
¥ 4268.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide
|
H626640-250mg
|
≥97% |
1038915-75-1 |
250mg
|
¥ 2558.9
|
期货,请咨询 |
|
0 |
阿拉丁 |